A new collaboration is set to enhance blockchain transparency in order to promote the further adoption of Bitcoin by mainstream financial institutions. LexisNexis Risk Solutions, an analytics provider for 100 of the top American banks and 80% of U.S. federal agencies, has teamed with blockchain intelligence company Elliptic for exposing criminals who use Bitcoin on the dark web .
The alliance, which was announced today, integrates LexisNexis Risk Solutions’ anti-money laundering data into Elliptic’s Bitcoin transaction monitoring and compliance products. As a result, Elliptic clients can obtain more insights than before by screening Bitcoin entities for links to sanctions, enforcements, politically exposed persons, adverse media and state owned companies.
“For the first time, Bitcoin companies can leverage bank-grade risk management practices to identify Bitcoin entities that appear on sanction and watch lists from around the world,” said Dr. James Smith, Elliptic CEO and co-founder. “Having this enriched data set built natively into Elliptic’s products takes Bitcoin AML and KYC controls to the next level.”
Elliptic will use LexisNexis platform and database to identify whether Bitcoin transactions are linked to identities that are related to fraud, anti-money laundering, corruption or terrorist financing. Tracking the Dark Web
Elliptic also revealed today that the largest dark marketplaces facilitate more than $250 million in annual sales. “The leading Bitcoin companies globally are already using Elliptic products to assess risk on more than $1 billion in Bitcoin transactions each month. By integrating LexisNexis Risk Solutions’ robust watchlist data, we are making it safe for a new wave of financial institutions to handle Bitcoin and bank Bitcoin companies.” said Dr. Smith.
“This alliance demonstrates how data, technology and analytics can be used in innovative ways to foster financial transparency from China to Germany to the U.S.,” said Thomas C. Brown, SVP of U.S. Commercial Markets and Global Market Development […]
